Top Back to top

Chronic Malignancies Working Party (CMWP)

The Chronic Malignancies Working Party promotes and conduct educational activities and clinical investigations on the role of hematopoietic cell transplantation in chronic malignancies such as chronic leukaemias, myelodysplastic syndromes, myeloproliferative and plasma cell disorders. 

The CMWP aims to contribute to improving outcomes for patients undergoing stem cell transplantation for chronic hematologic malignancies by the following means:

  1. Performing high quality retrospective registry studies
  2. Performing prospective clinical trials and non-interventional studies (NIS)
  3. Improving the quality of EBMT registry data
  4. Promoting scientific interaction by organising educational courses and scientific meetings
  5. Collaborating with national and international transplant- and disease-specific groups
  6. Disseminating knowledge to the transplant and non-transplant scientific communities, patient organisations and the lay public

Learn more about the CMWP

Structure

The CMWP consists of six subcommittees:

  1. Myelodysplastic syndromes (MDS) including Chronic Myelomonocytic Leukaemia (CMML)
  2. Plasma Cell Disease (PCD)
  3. Philadelphia-negative Myeloproliferative Neoplasms (Ph-neg MPN)
  4. Chronic Myeloid Leukaemia (CML)
  5. Chronic Lymphocytic Leukaemia (CLL)
  6. Practice Harmonisation and Guidelines (PH&G)

Each subcommittee will have a chair and one or two vice-chairs.
Vice-chairs should act as co-chairs and should be directly responsible for at least two studies. (Chairs of subcommittees should allocate at least two studies to each vice-chair)

The chair of the CMWP appoints the chairs and vice-chairs of subcommittees.
Subcommittee members who have served over four years on the board may be replaced to provide opportunities for other interested WP members.
It is a goal of the current chair to have the board reflect the international range of EBMT-affiliated centres.

Membership

Working Party membership is open to all physicians in EBMT-affiliated Transplant Centres.
Applicants from elsewhere are welcome to apply to join. The final decision will rest with the Chair of the Working Party. The secretary maintains the list of members.
If a member has not attended any meeting for two years, they will be deemed to have left the Working Party and will no longer receive group email communications from the Secretary.

CMWP Team

CMWP Publications List

Studies

Subcommittees & Members

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org